Cargando…
Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01
The development of allogeneic hematopoietic-stem-cell transplantation has improved the prognosis of younger acute myeloid leukemia (AML) patients. However, the outcome of older AML patients remains poor. The majority of AML patients are elderly. For elderly AML patients unfit for intensive chemother...
Autores principales: | Miyamoto, Kenichi, Minami, Yosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597606/ https://www.ncbi.nlm.nih.gov/pubmed/31111287 http://dx.doi.org/10.1007/s10147-019-01467-1 |
Ejemplares similares
-
Cutting Edge Molecular Therapy for Acute Myeloid Leukemia
por: Miyamoto, Kenichi, et al.
Publicado: (2020) -
Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19
por: Cook, Michael Roderick, et al.
Publicado: (2020) -
P1700: EARLY APPEARANCE OF CARDIOTOXICITY, IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES (HM)
por: Antoniadi, K., et al.
Publicado: (2022) -
Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01
por: Hosono, Naoko, et al.
Publicado: (2023) -
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)